VICKIE CHILDS: Open Payments
NPI 1659946655 · TROY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,614 in 94 payments from 17 companies in 2025. Trend: 2023 $1,366 · 2024 $1,587 · 2025 $1,614
Food & beverage: $1,439Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $297 |
| Lilly USA, LLC | 20 | $281 |
| AstraZeneca Pharmaceuticals LP | 11 | $197 |
| Novo Nordisk Inc | 12 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $142 |
| Astellas Pharma US Inc | 5 | $99 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Inspire Medical Systems, Inc. | 2 | $41 |
Products named: PROLIA, Kerendia, MOUNJARO, JARDIANCE, BREZTRI, Ozempic, Veozah, EVENITY.
Industry payments across AL — which companies pay providers there.
